|
1
|
Zhu J, Eichler F, Biffi A, Duncan CN,
Williams DA and Majzoub JA: The changing face of
adrenoleukodystrophy. Endocr Rev. 41:577–593. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Palakuzhiyil SV, Christopher R and Chandra
SR: Deciphering the modifiers for phenotypic variability of
X-linked adrenoleukodystrophy. World J Biol Chem. 11:99–111.
2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schmidt S, Träber F, Block W, Keller E,
Pohl C, von Oertzen J, Schild H, Schlegel U and Klockgether T:
Phenotype assignment in symptomatic female carriers of X-linked
adrenoleukodystrophy. J Neurol. 248:36–44. 2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Engelen M, Barbier M, Dijkstra IM, Schür
R, de Bie RM, Verhamme C, Dijkgraaf MG, Aubourg PA, Wanders RJ, van
Geel BM, et al: X-linked adrenoleukodystrophy in women: A
cross-sectional cohort study. Brain. 137:693–706. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Salsano E, Tabano S, Sirchia SM,
Colapietro P, Castellotti B, Gellera C, Rimoldi M, Pensato V,
Mariotti C, Pareyson D, et al: Preferential expression of mutant
ABCD1 allele is common in adrenoleukodystrophy female carriers but
unrelated to clinical symptoms. Orphanet J Rare Dis.
7(10)2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ye YJ, Liu B and Qin BZ: Clinical analysis
of patients of cirrhosis complicated with adrenal insufficiency.
Eur Rev Med Pharmacol Sci. 20:2667–2672. 2016.PubMed/NCBI
|
|
7
|
Hadj Ahmed S, Koubaa N, Kharroubi W,
Zarrouk A, Mnari A, Batbout F, Gamra H, Hammami S, Lizard G and
Hammami M: Identification of long and very long chain fatty acids,
plasmalogen-C16:0 and phytanic acid as new lipid biomarkers in
Tunisian coronary artery disease patients. Prostaglandins Other
Lipid Mediat. 131:49–58. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Richards S, Aziz N, Bale S, Bick D, Das S,
Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al:
Standards and guidelines for the interpretation of sequence
variants: A joint consensus recommendation of the American College
of Medical Genetics and Genomics and the Association for molecular
pathology. Genet Med. 17:405–424. 2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
He WB, Du J, Xie PY, Zhou S, Zhang YX, Lu
GX, Lin G, Li W and Tan YQ: X-chromosome inactivation pattern of
amniocytes predicts the risk of dystrophinopathy in fetal carriers
of DMD mutations. PrenatDiagn. 39:603–608. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Olgac A, Kasapkara ÇS, Derinkuyu B, Yüksel
D, Çetinkaya S, Aksoy A, Ceylaner S, Güleray N, Yeşilipek A, Aydın
Hİ, et al: Retrospective evaluation of patients with X-linked
adrenoleukodystrophy with a wide range of clinical presentations: A
single center experience. J Pediatr Endocrinol Metab. 34:1169–1179.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Engelen M, Kemp S, de Visser M, van Geel
BM, Wanders RJ, Aubourg P and Poll-The BT: X-linked
adrenoleukodystrophy (X-ALD): Clinical presentation and guidelines
for diagnosis, follow-up and management. Orphanet J Rare Dis.
7(51)2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Mohn A, Polidori N, Aiello C, Rizzo C,
Giannini C, Chiarelli F and Cappa M: ABCD1 gene mutation in an
Italian family with X-linkedadrenoleukodystrophy: Case series.
Endocrinol Diabetes Metab Case Rep. 2021:20–0125. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Moser HW, Loes DJ, Melhem ER, Raymond GV,
Bezman L, Cox CS and Lu SE: X-Linked adrenoleukodystrophy: Overview
and prognosis as a function of age and brain magnetic resonance
imaging abnormality. A study involving 372 patients.
Neuropediatrics. 31:227–239. 2000.PubMed/NCBI View Article : Google Scholar
|
|
14
|
ALD info: The information platform to all
aspects of adrenoleukodystrophy and the worldwide registry for
ABCD1 variants. https://adrenoleukodystrophy.info/. Accessed March 1,
2022.
|
|
15
|
Campopiano R, Femiano C, Chiaravalloti MA,
Ferese R, Centonze D, Buttari F, Zampatti S, Fanelli M, Amatori S,
D'Alessio C, et al: A large family with p.Arg554His mutation in
ABCD1: Clinical features and genotype/phenotype correlation in
female carriers. Genes (Basel). 12(775)2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Horn MA, Retterstøl L, Abdelnoor M,
Skjeldal OH and Tallaksen CM: Adrenoleukodystrophy in Norway: High
rate of de novo mutations and age-dependent penetrance. Pediatr
Neurol. 48:212–219. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Penman RW: Addison's disease in
association with spastic paraplegia. Br Med J.
1(402)1960.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shvetsova E, Sofronova A, Monajemi R,
Gagalova K, Draisma HHM, White SJ, Santen GWE, Chuva de Sousa Lopes
SM, Heijmans BT, van Meurs J, et al: Skewed X-inactivation is
common in the general female population. Eur J Hum Genet.
27:455–465. 2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pereira G and Dória S: X-chromosome
inactivation: Implications in human disease. J Genet.
100(63)2021.PubMed/NCBI
|
|
20
|
Wang Z, Yan A, Lin Y, Xie H, Zhou C and
Lan F: Familial skewed x chromosome inactivation in
adrenoleukodystrophy manifesting heterozygotes from a Chinese
pedigree. PLoS One. 8(e57977)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Maier EM, Kammerer S, Muntau AC, Wichers
M, Braun A and Roscher AA: Symptoms in carriers of
adrenoleukodystrophy relate to skewed X inactivation. Ann Neurol.
52:683–688. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Watkiss E, Webb T and Bundey S: Is skewed
X inactivation responsible for symptoms in female carriers for
adrenoleucodystrophy? J Med Genet. 30:651–654. 1993.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yang C, Yu Z, Zhang W, Cao L, Ouyang W, Hu
F, Zhang P, Bai X and Ruan C: A novel missense mutation, p.
Phe360Cys, in FIX gene results in haemophilia B in a female patient
with skewed X-inactivation. Haemophilia. 24:e68–e70.
2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Miller CH and Bean CJ: Genetic causes of
haemophilia in women and girls. Haemophilia. 27:e164–e179.
2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Viggiano E, Picillo E, Ergoli M, Cirillo
A, Del Gaudio S and Politano L: Skewed X-chromosome inactivation
plays a crucial role in the onset of symptoms in carriers of Becker
muscular dystrophy. J Gene Med. 19:2017.PubMed/NCBI View
Article : Google Scholar
|
|
26
|
Viggiano E, Ergoli M, Picillo E and
Politano L: Determining the role of skewed X-chromosome
inactivation in developing muscle symptoms in carriers of Duchenne
muscular dystrophy. Hum Genet. 135:685–698. 2016.PubMed/NCBI View Article : Google Scholar
|
